In the latest issue...
- Treatment options for central serous chorioretinopathy
- Cognitive impairment and diabetic retinopathy - is there a link?
- Lucentis® or Avastin®? Implications of the first-year CATT results
- Tuberculous scleritis - the dangers of delayed diagnosis
Contents
Editorial advisory board
Editors:
Dr Peter J Francis
Editorial Advisory Board
- Professor Hélène Dolfus, Service de génétique, Hôpital des Hautes Pierres, Strasbourg, France
- Miss Beth Edmunds, Consultant Ophthalmic Surgeon, Princess Royal University Hospital, Orpington, Kent, UK
- Dr Christina Flaxel, Associate Professor, Casey Eye Institute, Portland, Oregon, USA
- Professor Clare Gilbert, Professor of Ophthalmic Epidemiology, Clinical Research Unit, London School of Hygiene & Tropical Medicine, London, UK
- Professor Chris Lohmann, Director, University Eye Clinic, University of Regensburg, Regensburg, Germany
- Dr Giacomo Pannozzo, Teclo, Vitreoretinal Service, Verona, Italy
- Professor Miles Stanford, Professor of Ophthalmology, Medical Eye Unit, St Thomas’ Hospital, London, UK
- Professor Donald Tan, Professor of Ophthalmology, Singapore National Eye Centre, Singapore